Caption Management 13F: New $5.6M Stake in The Chemours (CC)
Caption Management filed a regulatory report disclosing a new stake in The Chemours Company.
Reviewed by automated data checks against the source filing. How we make and check alerts
Caption Management opened a new position of 270,800 shares in The Chemours Company ($CC), according to a 13F filing with the SEC dated May 15, 2026. It reported 270,800 shares worth $5.56 million at the end of the quarter.
Since the filing, $CC is down 7.6% after 1 week, down 3.0% after 1 month and down 44.6% to date (from the $23 close on May 15, 2026).
Find the original: Caption Management 13F filings on SEC EDGAR
CC
The Chemours Company
Key Points
- Caption Management opened a new position in The Chemours Company by purchasing 270,800 shares valued at approximately $5.56 million during the period.
- The Chemours Company shares trade alongside a forward P/E ratio of 7.54, with a forward-looking consensus rating pointing toward a buy recommendation.
- Wall Street firms have recently adjusted targets for the specialty chemical maker, including Mizuho revising its rating and target in October 2026.
Get $CC trade alerts by text
We text you when insiders, Congress or big funds trade $CC. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated The Chemours Company alert may contain errors. Disclosures
Caption Management Establishes New Stake
Caption Management filed a Form 13F with the Securities and Exchange Commission detailing a new investment in The Chemours Company NYSE: CC. The fund bought 270,800 shares of the specialty chemical maker during the period. Based on the cost basis of $17.47 per share, the holding carried an estimated value of $5.56 million at the time of the record. Because 13F filings look backward at holdings from the close of a past quarter, this position report reflects the fund's portfolio at that moment and might not show its current trades today.
The Chemours Company Stock Valuation
Shares of The Chemours Company trade around $20.52. The company carries a forward P/E ratio of 7.54, which evaluates the share price against projected future earnings per share. Investors tracking technical indicators note that the stock has moved between a 52-week low of $10.44 and a 52-week high of $28.67. Its 50-day moving average sits at $16.01, while its 200-day moving average stands at $18.28.
Recent Analyst Ratings and Adjustments
Several research firms have updated their outlooks on the specialty chemical producer in recent months. On October 14, 2026, Mizuho adjusted its stance by downgrading the stock to a neutral rating and setting a $15.00 price target. Days earlier on October 13, 2026, Barclays initiated coverage with an equal-weight rating and a $16.00 price target. UBS maintained a neutral rating on October 5, 2026, lowering its target to $16.00 from $18.00. Earlier in the autumn, Mizuho maintained an outperform rating on September 30, 2026, with an 18.00 target. JP Morgan maintained a neutral rating on August 13, 2026, while BMO Capital kept an outperform rating on the same day with an $18.00 target. UBS previously adjusted its view on August 10, 2026, moving to a neutral rating and an $18.00 target, and RBC Capital maintained an outperform rating on August 6, 2026, with a $22.00 target. Across the broader analyst community, the stock holds a consensus buy rating with a mean price target of $18.78 based on 9 analyst opinions.
Specialty Chemical Operations
The Chemours Company operates in the basic materials sector, creating performance chemicals used across industrial and consumer markets. Its business is split into segments that manufacture thermal management solutions, titanium dioxide pigments for coatings and plastics, and advanced polymer resins used in electronics and energy applications. The firm employs 5,700 people and is headquartered in Wilmington, Delaware.
What to Watch at The Chemours Company
Market participants will look to upcoming regulatory filings to see if Caption Management adjusts its exposure to the company. The next major update for the firm will arrive when management releases its scheduled financial results on November 5, 2026, offering fresh details on revenue, margins, and earnings performance.
Related Filing Alerts
Source: Caption Management's 13F filing on $CC (May 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Caption Management 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts